Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.

Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP.

PLoS One. 2019 Feb 28;14(2):e0212907. doi: 10.1371/journal.pone.0212907. eCollection 2019.

2.

The future of guidelines: Primary care focused, patient oriented, evidence based and simplified.

Allan GM, McCormack JP, Korownyk C, Lindblad AJ, Garrison S, Kolber MR.

Maturitas. 2017 Jan;95:61-62. doi: 10.1016/j.maturitas.2016.08.015. Epub 2016 Aug 28. No abstract available.

PMID:
27612638
3.

Guidelines for treating risk factors should include tools for shared decision making.

Yudkin JS, Kavanagh J, McCormack JP.

BMJ. 2016 Jun 14;353:i3147. doi: 10.1136/bmj.i3147. No abstract available.

PMID:
27302041
4.

Financial Incentives and Cholesterol Levels.

Lesser LI, McCormack JP.

JAMA. 2016 Apr 19;315(15):1657-8. doi: 10.1001/jama.2016.0309. No abstract available.

PMID:
27092834
6.

Representations of the health value of vitamin D supplementation in newspapers: media content analysis.

Caulfield T, Clark MI, McCormack JP, Rachul C, Field CJ.

BMJ Open. 2014 Dec 31;4(12):e006395. doi: 10.1136/bmjopen-2014-006395.

7.

Changes in diabetes-related complications in the United States.

Martin SA, McCormack JP, Newman DH.

N Engl J Med. 2014 Jul 17;371(3):284-5. doi: 10.1056/NEJMc1406009. No abstract available.

PMID:
25014699
8.

No evidence base for monitoring aminoglycoside levels.

McCormack JP.

BMJ. 2012 Oct 30;345:e7264; author reply e7265. doi: 10.1136/bmj.e7264. No abstract available.

PMID:
23112060
9.

Is bigger better? An argument for very low starting doses.

McCormack JP, Allan GM, Virani AS.

CMAJ. 2011 Jan 11;183(1):65-9. doi: 10.1503/cmaj.091481. Epub 2010 Oct 4. No abstract available.

10.

Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

McCormack JP, Allan GM.

PLoS Med. 2010 Feb 2;7(2):e1000196. doi: 10.1371/journal.pmed.1000196. No abstract available.

11.

Number needed to treat and baseline risks.

McCormack JP.

CMAJ. 2008 Nov 18;179(11):1174. doi: 10.1503/cmaj.1080110. No abstract available.

12.

Adding "value" to clinical practice guidelines.

McCormack JP, Loewen P.

Can Fam Physician. 2007 Aug;53(8):1326-7.

13.

Rebuttal: Do beta-blockers have a role in treating hypertension? No.

McCormack JP.

Can Fam Physician. 2007 May;53(5):800-3. English, French. No abstract available.

14.

Do beta-blockers have a role in treating hypertension? No.

McCormack JP.

Can Fam Physician. 2007 Apr;53(4):614-21. Review. English, French. No abstract available.

15.

Outcomes of bupropion therapy for smoking cessation during routine clinical use.

Paluck EC, McCormack JP, Ensom MH, Levine M, Soon JA, Fielding DW.

Ann Pharmacother. 2006 Feb;40(2):185-90. Epub 2006 Jan 24.

PMID:
16434561
16.

Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?

McCormack JP, Dolovich L, Levine M, Burns S, Nair K, Cassels A, Mann K, Gray J.

Health Expect. 2003 Dec;6(4):281-9.

17.

Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.

Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.

CMAJ. 2003 Apr 29;168(9):1133-7.

18.

Digging for data from the COX-2 trials.

McCormack JP, Rangno R.

CMAJ. 2002 Jun 25;166(13):1649-50. No abstract available.

19.

An emotional-based medicine approach to monitoring once-daily aminoglycosides.

McCormack JP.

Pharmacotherapy. 2000 Dec;20(12):1524-7. No abstract available.

PMID:
11130226
20.

Plasma concentration of flumazenil following intranasal administration in children.

Scheepers LD, Montgomery CJ, Kinahan AM, Dunn GS, Bourne RA, McCormack JP.

Can J Anaesth. 2000 Feb;47(2):120-4.

PMID:
10674504
21.

An easier approach to estimating risk of coronary heart disease and stroke.

McCormack JP, Levine M, Rangno RE.

Circulation. 1999 Apr 27;99(16):2219. No abstract available.

PMID:
10217664
22.

Patients offered treatment for CHD need full information to make decision.

McCormack JP, Levine M, Rangno RE.

BMJ. 1998 Mar 28;316(7136):1021-2. No abstract available. Erratum in: BMJ 1998 May 2;316(7141):1391. McCormack P [corrected to McCormack JP].

23.

A simpler approach to pharmacokinetic dosage adjustments.

McCormack JP, Carleton B.

Pharmacotherapy. 1997 Nov-Dec;17(6):1349-51. Review. No abstract available.

PMID:
9399625
24.

Simple approach to dosage adjustment in patients with renal impairment.

McCormack JP, Cooper J, Carleton B.

Am J Health Syst Pharm. 1997 Nov 1;54(21):2505-9. No abstract available.

PMID:
9359960
26.

Plasma concentrations after high-dose (45 mg.kg-1) rectal acetaminophen in children.

Montgomery CJ, McCormack JP, Reichert CC, Marsland CP.

Can J Anaesth. 1995 Nov;42(11):982-6.

PMID:
8590508
27.
28.

Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosing.

Brown G, McCormack JP.

Intensive Care Med. 1994;20(3):243-4. No abstract available.

PMID:
8014297
29.

Inadequate treatment of pain in ambulatory HIV patients.

McCormack JP, Li R, Zarowny D, Singer J.

Clin J Pain. 1993 Dec;9(4):279-83.

PMID:
8118093
30.

Meaningful interpretation of risk reduction from clinical drug trials.

McCormack JP, Levine M.

Ann Pharmacother. 1993 Oct;27(10):1272-7.

PMID:
8251698
31.

A comparison of regularly dosed oral morphine and on-demand intramuscular morphine in the treatment of postsurgical pain.

McCormack JP, Warriner CB, Levine M, Glick N.

Can J Anaesth. 1993 Sep;40(9):819-24.

PMID:
8403175
32.

Read "with caution".

McCormack JP, Stratton TP, Rangno RR.

Ann Pharmacother. 1993 Jun;27(6):794-5. No abstract available.

PMID:
8329810
33.

Drug concentration monitoring. An approach to rational use.

Brown GR, Miyata M, McCormack JP.

Clin Pharmacokinet. 1993 Mar;24(3):187-94. Review. No abstract available.

PMID:
8462227
34.

Disagreement with liability for failure to monitor serum gentamicin concentrations.

McCormack JP, Brown GR.

Am J Hosp Pharm. 1992 Dec;49(12):2928-9. No abstract available.

PMID:
1481794
35.

Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks.

Wong CL, Warriner CB, McCormack JP, Clarke AM.

Can J Anaesth. 1992 May;39(5 Pt 1):504-8.

PMID:
1596977
36.

A critical reevaluation of the "therapeutic range" of aminoglycosides.

McCormack JP, Jewesson PJ.

Clin Infect Dis. 1992 Jan;14(1):320-39. Review.

PMID:
1571447
37.

Theophylline toxicity induced by tetracycline.

McCormack JP, Reid SE, Lawson LM.

Clin Pharm. 1990 Jul;9(7):546-9. No abstract available.

PMID:
2376112
38.

The use of regularly scheduled oral morphine in the treatment of post surgical pain secondary to total hip arthroplasty.

McCormack JP, Warriner CB, Levine M, Forster-Coull J.

Can J Anaesth. 1990 May;37(4 Pt 2):S57. No abstract available.

PMID:
2361300
39.

Comment: unusual digoxin concentrations.

Levine M, McCormack JP.

DICP. 1989 Sep;23(9):717-8. No abstract available.

PMID:
2800594
40.

Comment: impact of a kinetic service on aminoglycoside patients.

McCormack JP.

DICP. 1989 Jul-Aug;23(7-8):622. No abstract available.

PMID:
2763592
41.

Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.

McCormack JP, Schentag JJ.

Drug Intell Clin Pharm. 1987 Feb;21(2):187-92.

PMID:
3829911
42.

Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.

Pleasants RA, Gadsden RH Sr, McCormack JP, Piveral K, Sawyer WT.

Clin Pharm. 1986 Oct;5(10):810-6.

PMID:
3780148

Supplemental Content

Loading ...
Support Center